All Stories

  1. Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer

    Article • Gynecologic Oncology, May 2024, Elsevier

    Dr. Andrei Fodor

  2. Re: Marcin Miszczyk, Pawel Rajawa, Takafumi Yanagisawa, et al. The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Eur Urol. In press. https://doi.org/10...

    Article • European Urology, March 2024, Elsevier

    Dr. Andrei Fodor

  3. Comparing Performances of Predictive Models of Toxicity after Radiotherapy for Breast Cancer Using Different Machine Learning Approaches

    Article • Cancers, February 2024, MDPI AG

    Dr. Andrei Fodor

  4. Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study

    Article • Radiotherapy and Oncology, February 2024, Elsevier

    Dr. Andrei Fodor

  5. Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience

    Article • Tumori Journal, November 2023, SAGE Publications

    Dr. Andrei Fodor

  6. Real-world validation of Artificial Intelligence-based Computed Tomography auto-contouring for prostate cancer radiotherapy planning

    Article • Physics and Imaging in Radiation Oncology, October 2023, Elsevier

    Dr. Andrei Fodor

  7. Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Ma...

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2023, Elsevier

    Dr. Andrei Fodor

  8. Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt

    Article • Cancers, September 2023, MDPI AG

    Dr. Andrei Fodor

  9. Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial

    Article • European Journal of Nuclear Medicine and Molecular Imaging, September 2023, Springer Science + Business Media

    Dr. Andrei Fodor

  10. Knowledge-based plan optimization for prostate SBRT delivered with CyberKnife according to RTOG0938 protocol

    Article • Physica Medica, June 2023, Elsevier

    Dr. Andrei Fodor

  11. Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study

    Article • European Urology Oncology, June 2023, Elsevier

    Dr. Andrei Fodor

  12. A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study

    Article • Clinical and Translational Radiation Oncology, March 2023, Elsevier

    Dr. Andrei Fodor

  13. Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy?

    Article • Critical Reviews in Oncology/Hematology, January 2023, Elsevier

    Dr. Andrei Fodor

  14. CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer: a single institute pilot study

    Article • Strahlentherapie und Onkologie, December 2022, Springer Science + Business Media

    Dr. Andrei Fodor

  15. Ovarian Cancer Radiosensitivity: What Have We Understood So Far?

    Article • Life, December 2022, MDPI AG

    Dr. Andrei Fodor

  16. In Regard to Zureick et al.

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2022, Elsevier

    Dr. Andrei Fodor

  17. Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse

    Article • iScience, November 2022, Elsevier

    Dr. Andrei Fodor

  18. Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation

    Article • Radiotherapy and Oncology, October 2022, Elsevier

    Dr. Andrei Fodor

  19. Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy

    Article • Physics and Imaging in Radiation Oncology, July 2022, Elsevier

    Dr. Andrei Fodor

  20. Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients

    Article • Clinical Breast Cancer, June 2022, Elsevier

    Dr. Andrei Fodor

  21. Could the association of sunitinib and stereotactic ablative radiotherapy lead to abscopal effect in metastatic renal cell carcinoma?

    Article • Journal of Clinical Images and Medical Case Reports, April 2022, Open Source Publications

    Dr. Andrei Fodor

  22. Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study

    Article • Minerva Urology and Nephrology, March 2022, Edizioni Minerva Medica

    Dr. Andrei Fodor

  23. The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study

    Article • Minerva Urology and Nephrology, March 2022, Edizioni Minerva Medica

    Dr. Andrei Fodor

  24. Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

    Article • International Journal of Gynecological Cancer, February 2022, BMJ

    Dr. Andrei Fodor

  25. A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study

    Article • Radiotherapy and Oncology, January 2022, Elsevier

    Dr. Andrei Fodor

  26. Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors

    Article • Critical Reviews in Oncology/Hematology, December 2021, Elsevier

    Dr. Andrei Fodor

  27. Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis

    Article • La radiologia medica, November 2021, Springer Science + Business Media

    Dr. Andrei Fodor

  28. A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer: The LaIT-SABR Study

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2021, Elsevier

    Dr. Andrei Fodor

  29. Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer

    Article • Cancers, October 2021, MDPI AG

    Dr. Andrei Fodor

  30. 933 A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD)

    Article • October 2021, BMJ

    Dr. Andrei Fodor

  31. Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy

    Article • Frontiers in Oncology, August 2021, Frontiers

    Dr. Andrei Fodor

  32. In Regard to Wages et al and Leite et al

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2021, Elsevier

    Dr. Andrei Fodor

  33. Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost in a Large “Real-Life” Cohort of Consecutive Early-Stage Breast Cancer Patients

    Article • June 2021, Research Square

    Dr. Andrei Fodor

  34. Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study

    Article • Cancers, March 2021, MDPI AG

    Dr. Andrei Fodor

  35. Clinical Implementation of Knowledge-Based Automatic Plan Optimization for Helical Tomotherapy

    Article • Practical Radiation Oncology, March 2021, Elsevier

    Dr. Andrei Fodor

  36. Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review

    Article • International Journal of Gynecological Cancer, February 2021, BMJ

    Dr. Andrei Fodor

  37. Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?

    Article • The Breast, February 2021, Elsevier

    Dr. Andrei Fodor

  38. Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy

    Article • Clinical & Translational Oncology, January 2021, Springer Science + Business Media

    Dr. Andrei Fodor

  39. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)

    Article • Minerva Urologica e Nefrologica, November 2020, Edizioni Minerva Medica

    Dr. Andrei Fodor

  40. Residual intra-fraction error in robotic spinal stereotactic body radiotherapy without immobilization devices

    Article • Physics and Imaging in Radiation Oncology, October 2020, Elsevier

    Dr. Andrei Fodor

  41. Virtual Tangential-fields Arc Therapy (ViTAT) for whole breast irradiation: Technique optimization and validation

    Article • Physica Medica, September 2020, Elsevier

    Dr. Andrei Fodor

  42. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study

    Article • World Journal of Urology, August 2020, Springer Science + Business Media

    Dr. Andrei Fodor

  43. Which oligometastatic PCa should be treated on metastases only?

    Article • JAMA Oncology, April 2020, American Medical Association (AMA)

    Dr. Andrei Fodor

  44. Concomitant RT to primary and metastases in metastatic PCa

    Article • British Journal of Radiology, April 2020, British Institute of Radiology

    Dr. Andrei Fodor

  45. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent

    Article • Lung Cancer, March 2020, Elsevier

    Dr. Andrei Fodor

  46. Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group

    Article • La radiologia medica, February 2020, Springer Science + Business Media

    Dr. Andrei Fodor

  47. Patients with MPM treated with high dose RT have higher survival

    Article • Journal of Thoracic Oncology, December 2019, Elsevier

    Dr. Andrei Fodor

  48. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

    Article • PLoS ONE, November 2019, PLOS

    Dr. Andrei Fodor, ALessio BRuni

  49. A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

    Article • The Oncologist, October 2019, Alphamed Press

    Dr. Andrei Fodor

  50. Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option

    Article • International Journal of Gynecological Cancer, September 2019, BMJ

    Dr. Andrei Fodor

  51. European review of treatment strategies in prostate cancer PET positive relapse.

    Article • European Urology, July 2019, Elsevier

    Dr. Andrei Fodor

  52. EP-1993 Evidence of CTV underdosing due to anatomical changes during breast Helical Tomotherapy

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr. Andrei Fodor

  53. EP-1553 High-dose hypofractionated helical IG-IMRT in high-risk prostate cancer patients

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr. Andrei Fodor

  54. EP-1303 Hypofractionated adjuvant radiotherapy in elderly low risk breast cancer patients: loss or gain?

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr. Andrei Fodor

  55. EP-1640 Radical radiotherapy in elderly prostate cancer patients: a monoinstitutional experience

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr. Andrei Fodor

  56. PO-0973 Residual intra-fraction error in nonimmobilized patients treated with tracked robotic spinal SBRT

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr. Andrei Fodor

  57. EP-1482 Stereotactic rt in ovarian cancer: multicentric retrospective pooled analysis (MITO-RT project)

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr. Andrei Fodor

  58. Imaging targeted treatments versus extended salvage lymph node dissection for patients with a single nodal recurrence of prostate cancer: A comparative analysis from a large multi-institutional series

    Article • European Urology Supplements, March 2019, Elsevier

    Dr. Andrei Fodor

  59. Important results from an Italian national survey on prostate cancer diagnosis and treatment.

    Article • Urologia Internationalis, January 2019, Karger Publishers

    Dr. Andrei Fodor

  60. Radiotherapy for oligometastatic cancer: a survey among radiation oncologists of Lombardy (AIRO-Lombardy), Italy

    Article • La radiologia medica, December 2018, Springer Science + Business Media

    Dr. Andrei Fodor

  61. Moderately Hypofractionated Helical IMRT, FDG–PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs

    Article • Clinical Lung Cancer, September 2018, Elsevier

    Dr. Andrei Fodor

  62. Important results from an Italian national survey on prostate cancer diagnosis and treatment.

    Article • Health and Quality of Life Outcomes, June 2018, Springer Science + Business Media

    Dr. Andrei Fodor

  63. FDG-PET/CT predictive value in MPM.

    Article • European Journal of Nuclear Medicine and Molecular Imaging, June 2018, Springer Science + Business Media

    Dr. Andrei Fodor

  64. Review of current status in prostate cancer PET positive relapse.

    Article • World Journal of Urology, May 2018, Springer Science + Business Media

    Dr. Andrei Fodor

  65. EP-1593: Hypofractionated IGRT in high-intermediate and high/very-high risk prostate cancer patients

    Article • Radiotherapy and Oncology, April 2018, Elsevier

    Dr. Andrei Fodor

  66. EP-1221: Hypoxia imaging with 18F-FAZA PET/CT in Radiotherapy Planning for High Grade Gliomas

    Article • Radiotherapy and Oncology, April 2018, Elsevier

    Dr. Andrei Fodor

  67. EP-1191: Outcomes of a mono-institutional experience of IG-IMRT in Glioblastoma

    Article • Radiotherapy and Oncology, April 2018, Elsevier

    Dr. Andrei Fodor

  68. EP-1390: Salvage (postponed) hypofractionated tomotherapy for progressive MPM in patients with intact lungs

    Article • Radiotherapy and Oncology, April 2018, Elsevier

    Dr. Andrei Fodor

  69. Relationship between local relapse and distant metastases in prostate cancer

    Article • European Journal of Nuclear Medicine and Molecular Imaging, February 2018, Springer Science + Business Media

    Dr. Andrei Fodor

  70. 11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients

    Article • Current Radiopharmaceuticals, November 2017, Bentham Science Publishers

    Dr. Andrei Fodor, Giampiero Giovacchini, Andrea Ciarmiello, Elena Incerti

  71. Quality of Life After Prostate Cancer Diagnosis: Data from the Pros-IT CNR

    Article • European Urology Focus, October 2017, Elsevier

    Dr. Andrei Fodor

  72. EP-1319: “Adjuvant”/ radical radiotherapy in prostate cancer patients with synchronous bone oligometastasis

    Article • Radiotherapy and Oncology, May 2017, Elsevier

    Dr. Andrei Fodor

  73. PO-0651: Five year outcome and soft tissue toxicity of breast cancer hypofractionated adjuvant radiotherapy

    Article • Radiotherapy and Oncology, May 2017, Elsevier

    Dr. Andrei Fodor

  74. EP-1159: Hypofractionated adjuvant radiotherapy and concomitant trastuzumab for breast cancer: 5-year results

    Article • Radiotherapy and Oncology, May 2017, Elsevier

    Dr. Andrei Fodor

  75. EP-1318: Is hypofractionation combined to WPRT effective in high risk prostate cancer patients?

    Article • Radiotherapy and Oncology, May 2017, Elsevier

    Dr. Andrei Fodor

  76. EP-1315: Prostate cancer lymph nodal disease: SBRT only or extensive prophylactic irradiation and boost?

    Article • Radiotherapy and Oncology, May 2017, Elsevier

    Dr. Andrei Fodor

  77. PO-0730: The independent benefit deriving from high doses and WPRT in salvage post-prostatectomy radiotherapy

    Article • Radiotherapy and Oncology, May 2017, Elsevier

    Dr. Andrei Fodor

  78. In Regard to Pommier et al

    Article • International Journal of Radiation Oncology*Biology*Physics, April 2017, Elsevier

    Dr. Andrei Fodor

  79. Pros-IT CNR: an Italian prostate cancer monitoring project

    Article • Aging Clinical and Experimental Research, February 2017, Springer Science + Business Media

    Dr. Andrei Fodor

  80. Why prostate cancer bone and lymph nodal metastases are different?

    Article • Translational Cancer Research, February 2017, AME Publishing Company

    Dr. Andrei Fodor

  81. Re: Daniel E. Spratt, Herbert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.043

    Article • European Urology, January 2017, Elsevier

    Dr. Andrei Fodor

  82. In Regard to Perrier et al

    Article • International Journal of Radiation Oncology*Biology*Physics, December 2016, Elsevier

    Dr. Andrei Fodor

  83. Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I–II Study

    Article • Clinical Oncology, August 2016, Elsevier

    Dr. Andrei Fodor

  84. radiotherapy for prostate cancer lymph nodal recurrence

    Article • BJU International, May 2016, Wiley

    Dr. Andrei Fodor

  85. EP-1079: Clinical outcomes in locally advanced oropharyngeal cancer 18FDG PET-guided dose escalation IMRT-SIB

    Article • Radiotherapy and Oncology, April 2016, Elsevier

    Dr. Andrei Fodor

  86. PO-0689: Outcome predictors for moderate hypofractionated tomotherapy in Malignant Pleural Mesothelioma

    Article • Radiotherapy and Oncology, April 2016, Elsevier

    Dr. Andrei Fodor

  87. PO-0753: Prospective evaluation of urinary function in patients with prostate cancer treated with RT

    Article • Radiotherapy and Oncology, April 2016, Elsevier

    Dr. Andrei Fodor

  88. EP-1349: Long term results of a phase I-II study of moderate hypofractionated IGRT in prostate cancer

    Article • Radiotherapy and Oncology, April 2016, Elsevier

    Dr. Andrei Fodor

  89. EP-1347: Could “radical” RT be a reasonable choice in bone oligometastatic prostate cancer patients?

    Article • Radiotherapy and Oncology, April 2016, Elsevier

    Dr. Andrei Fodor

  90. 553 Salvage tomotherapy choline PET/CT guided for prostate cancer lymph nodal recurrence

    Article • European Urology Supplements, March 2016, Elsevier

    Dr. Andrei Fodor

  91. 61 Prophylactic irradiation of pelvic lymph-nodal area after prostatectomy does not increase the risk of second neoplasms: A single institution analysis of 1109 patients with 10 years follow-up

    Article • European Urology Supplements, March 2016, Elsevier

    Dr. Andrei Fodor

  92. 684 Could “radical” RT be a reasonable therapeutic option in bone oligometastatic prostate cancer patients?

    Article • European Urology Supplements, March 2016, Elsevier

    Dr. Andrei Fodor

  93. 676 Prospective evaluation of urinary function in patients with prostate cancer treated with external beam radiation therapy

    Article • European Urology Supplements, March 2016, Elsevier

    Dr. Andrei Fodor

  94. Five-Year Outcomes and Late Toxicity in Prostate Cancer Patients Treated With Moderate Hypofractionated Helical Tomotherapy and Simultaneous Integrated Boost in a Phase 1-2 Study

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

    Dr. Andrei Fodor

  95. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?

    Article • Journal of Nuclear Medicine, September 2015, Society of Nuclear Medicine

    Dr. Andrei Fodor

  96. 623 Impact on anxiety and depression of urinary symptoms and incontinence after postprostatectomy radiotherapy in the first year after treatment

    Article • European Urology Supplements, April 2015, Elsevier

    Dr. Andrei Fodor

  97. PO-0719: Excellent 5 year outcome with image guided moderate hypofractionation in prostate cancer : phase I-II study results

    Article • Radiotherapy and Oncology, April 2015, Elsevier

    Dr. Andrei Fodor

  98. EP-1230: The level of lymphopenia inversely correlates with the risk for late urinary toxicity after WPRTfor prostate cancer

    Article • Radiotherapy and Oncology, April 2015, Elsevier

    Dr. Andrei Fodor

  99. OC-0321: Impact of urinary symptoms and incontinence on anxiety and depression 1 year after postprostatectomy radiotherapy

    Article • Radiotherapy and Oncology, April 2015, Elsevier

    Dr. Andrei Fodor

  100. EP-1157 FDG-PET guided dose escalation with TomoTherapy for locally advanced oropharyngeal cancer

    Article • Radiotherapy and Oncology, April 2015, Elsevier

    Dr. Andrei Fodor

  101. Higher-than-expected Severe (Grade 3–4) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients

    Article • European Urology, December 2014, Elsevier

    Dr. Andrei Fodor

  102. Salvage therapy of small volume prostate cancer nodal failures: A review of the literature

    Article • Critical Reviews in Oncology/Hematology, April 2014, Elsevier

    Dr. Andrei Fodor

  103. 11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients

    Article • European Journal of Nuclear Medicine and Molecular Imaging, March 2014, Springer Science + Business Media

    Dr. Andrei Fodor

  104. PO-0724: Outcome of Choline PET-CT guided salvage hypofractionated Tomotherapy for lymph-nodal recurrent prostate cancer

    Article • Radiotherapy and Oncology, January 2014, Elsevier

    Dr. Andrei Fodor

  105. High-Dose Moderately Hypofractionated Tomotherapy for Prostate Cancer: 5-Year Results

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2013, Elsevier

    Dr. Andrei Fodor

  106. PD-0316: Forward planned intensity modulated whole breast hypofractionated radiotherapy: results in 500 patients

    Article • Radiotherapy and Oncology, March 2013, Elsevier

    Dr. Andrei Fodor

  107. PO-0713: Salvage post-prostatectomy hypofractionated high dose Tomotherapy with prophylactic whole pelvic irradiation

    Article • Radiotherapy and Oncology, March 2013, Elsevier

    Dr. Andrei Fodor

  108. PO-0717: Five year results of high dose moderately hypofractionated tomotherapy for prostate cancer

    Article • Radiotherapy and Oncology, March 2013, Elsevier

    Dr. Andrei Fodor

  109. EP-1099: PET/CT guided tomotherapy in gynecologic cancers

    Article • Radiotherapy and Oncology, March 2013, Elsevier

    Dr. Andrei Fodor

  110. PO-0701: Toxicity and outcome of recurrent prostate cancer patients treated with 11-C Choline PET/CT-guided tomotherapy

    Article • Radiotherapy and Oncology, March 2013, Elsevier

    Dr. Andrei Fodor

  111. EP-1120: Stereotactic ablative radiotherapy for small lung tumors by means of TomoTherapy: preliminary results and toxicity

    Article • Radiotherapy and Oncology, March 2013, Elsevier

    Dr. Andrei Fodor

  112. PO-0628 TOXICITY PREDICTORS FOR HYPOFRACTIONATED FIMRT IN BREAST CANCER

    Article • Radiotherapy and Oncology, May 2012, Elsevier

    Dr. Andrei Fodor

  113. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma

    Article • Strahlentherapie und Onkologie, October 2011, Springer Science + Business Media

    Dr. Andrei Fodor

  114. 868 poster SIMULTANEOUS INTEGRATED BOOST 18FDG-PET BASED HELICAL TOMOTHERAPY IN RADICAL LOCALLY ADVANCED HEAD AND NECK CANCER.

    Article • Radiotherapy and Oncology, May 2011, Elsevier

    Dr. Andrei Fodor

  115. 753 poster EARLY TOXICITY RESULTS OF A FORWARD PLANNED HYPOFRACTIONATED IMRT FOR WHOLE BREAST ADJUVANT TREATMENT

    Article • Radiotherapy and Oncology, May 2011, Elsevier

    Dr. Andrei Fodor

  116. Megavoltage CT Images of Helical Tomotherapy Unit for Radiation Treatment Simulation: Impact on Feasibility of Treatment Planning in a Prostate Cancer Patient with Bilateral Femoral Prostheses

    Article • Tumori Journal, March 2011, SAGE Publications

    Dr. Andrei Fodor

  117. Optimal Acute Toxicity for Concomitant Pelvic Irradiation with Tomotherapy in 153 Prostate Cancer Patients

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2010, Elsevier

    Dr. Andrei Fodor

  118. Hemithoracic Helical Tomotherapy (HT) for Malignant Pleural Mesothelioma (MPM): Early Results of a Dose Escalation Experience

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2009, Elsevier

    Dr. Andrei Fodor

  119. Dose Escalation for Prostate Cancer Using the Three-Dimensional Conformal Dynamic Arc Technique: Analysis of 542 Consecutive Patients

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2008, Elsevier

    Dr. Andrei Fodor

  120. Benefit on Biochemical Control of Adjuvant Radiation Therapy in Patients with Pathologically Involved Seminal Vesicles after Radical Prostatectomy

    Article • Tumori Journal, September 2007, SAGE Publications

    Dr. Andrei Fodor

  121. Meta-Analysis of Randomised Trials Comparing Gemcitabine-Based Doublets versus Gemcitabine Alone in Patients with Advanced and Metastatic Pancreatic Cancer

    Article • Drugs & Aging, January 2007, Springer Science + Business Media

    Dr. Andrei Fodor

  122. Cumulative meta-analysis of randomized trials comparing gemcitabine-based chemotherapy versus gemcitabine alone in patients with advanced or metastatic pancreatic cancer (PC)

    Article • Journal of Clinical Oncology, June 2005, American Society of Clinical Oncology (ASCO)

    Dr. Andrei Fodor

  123. Androgen Ablation Therapy Does not Increase the Risk of Late Morbidity following 3D-conformal Radiotherapy of Organ-confined Prostate Cancer: The Experience of the European Institute of Oncology

    Article • Tumori Journal, November 2004, SAGE Publications

    Dr. Andrei Fodor

  124. Finding dose–volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer

    Article • Radiotherapy and Oncology, November 2003, Elsevier

    Dr. Andrei Fodor

  125. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma (NPC)

    Article • European Journal of Cancer, September 1999, Elsevier

    Dr. Andrei Fodor

  126. A GPC method to determine the composition of two component copolymers

    Article • Polymer Bulletin, December 1992, Springer Science + Business Media

    Dr. Andrei Fodor